Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: Two case reports - 01/09/11
Abstract |
We present two cases of primary limited cutaneous perineal and genital extramammary Paget's disease (EMPD) that were successfully treated with imiquimod 5% cream. Clinical and histologic cure was confirmed after 7.5 to 12 weeks of monotherapy. Treatment-7associated morbidity is minimal compared with more invasive therapies, and self-application by the patient improves convenience and appeal. Imiquimod may offer a minimally invasive and promising therapeutic option for the treatment of limited cutaneous EMPD. The diagnosis and management of EMPD and the current literature regarding imiquimod therapy are reviewed. (J Am Acad Dermatol 2002;47:S229-35.)
Le texte complet de cet article est disponible en PDF. This article is part of a supplement sponsored by 3M Pharmaceuticals. |
Vol 47 - N° 4PB
P. S229-S235 - octobre 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?